Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading ...

China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis: Chengdu, China Thursday, December 26, 2024, 18:00 Hrs [IST] Ke ...

The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III clinical study to confirm the efficacy and safety of Stapokibart injection in treatment of patients with ...

Tom Contos is an avid runner. When he started experiencing rectal bleeding in March, he thought exercise could be the cause ...

RAPT obtains worldwide rights excluding China - - Jemincare receives $35 million upfront payment, up to $672.5 million in milestone payments and high single-digit to low-double ...

A Chicago man was stuck with a big medical bill after undergoing a colonoscopy that found no evidence of cancer. Here's why.

Emerging research shows mast cells play a role in the etiology of chronic rhinosinusitis with nasal polyps and may be a new ...

It starts with a stuffy nose, but soon your head feels like it’s caught in a vice. Nasal congestion and headaches often go ...

Health Canada has approved Omlyclo, the first omalizumab biosimilar in Canada, for the treatment of chronic idiopathic ...

Upstream Bio is leveraging TSLP targeting for respiratory disorders treatment, with IPO funds and upcoming Chronic ...

"This study was the first to establish vitamin D deficiency as an independent risk factor for the incidence of endometrial ...